Renal diseases are associated with a variety of haemopoietic changes. Anaemia parallels the degree of renal impairment and its most important cause is failure of renal erythropoietin secretion. Other factors include depressed red cell production and reduced red cell survival. Purpura and bleeding are predominantly due to platelet dysfunction and usually respond to dialysis. Cryoprecipitate and 1-deamino-8-d-arginine vasopressin may be of value in the bleeding patient. Abnormal coagulation with fibrin deposition in the microcirculation is now recognised as a mechanism of renal impairment. Plasma infusion and anticoagulants may be useful in the therapy of conditions in which this occurs. Plasma exchange is now used in the investigation and management of some varieties of immunologically mediated renal disease. Blood transfusion has been found to improve graft survival if given prior to renal transplantation and this effect is currently under active investigation.
ErslevA.J.Anaemia of chronic renal disease. Arch Intern Med1970; 126: 774–780.
2.
BrecherG., BessisM.Present status of spiculated red cells and their relationship to the discocyte-echinocyte transformation: a critical review. Blood1972; 40: 333–344.
3.
FisherJ.W.Mechanism of the anaemia of chronic renal failure. Nephron1980; 15: 106–111.
4.
RichI.N., HeitW., KubanekB.Extrarenal erythropoietin production of macrophages. Blood1982; 60: 1007–1018.
5.
CaroJ., BrownS., MillerO., MurrayT., ErslevA.J.Erythropoietin levels in uraemic nephric and anephric patients. J Lab Clin Med1979; 93: 449–458.
6.
ZaroulisC.G., HoffmanB.J., KouridesI.A.Serum concentrations of erythropoietin measured by haematologic disorders and chronic renal failure. Am J Haem1981; 11: 85–92.
7.
OhnoY., RegeA.B., FisherJ.W., BaronaJ.Inhibitors of erythroid colony-forming cells (CFU-E and BFU-E) in sera of azotaemic patients with anaemia of renal disease. J Lab Clin Med1978; 92: 916–923.
8.
KalmantiM., DainiakN., MartinoJ., DeweyM., KulkarniV., HowardD.Correlation of clinical and in vitro erythropoietic responses to androgens in renal failure. Kidney International1982; 22: 383–391.
9.
ZappacostaA.R., CaroJ., ErslevA.Normalization of haematocrit in patients with end stage renal disease on continuous ambulatory peritoneal dialysis. Am J Med1982; 72: 53–57.
10.
PodjarnyA., RathausM., KorzetsZ., BlumM., ZevinD., BernheimJ.Is anaemia of chronic renal failure related to secondary hyperparathyroidism. Arch Intern Med1981; 141: 453–455.
11.
EschbachJ.W., FunkD., AdamsonJ., KuhnI., ScribnerB.H., FinchC.A.Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Eng J Med1967; 276: 653–658.
12.
HockenA.G.Haemolysis in chronic renal failure. Nephron1982; 32: 28–31.
13.
ErslevA.J., ShapiroS.S.Haematologic aspects of renal failure. Diseases of the Kidney.StraussM.B., WeltL.G. eds. Little, Brown, Boston1971; 273–306.
14.
GiovannettiS., CioniL., BalestriP.L., BiaginiM.Evidence that guanidines and some related compounds cause haemolysis in chronic uraemia. Clin Sci1968; 34: 141–148.
15.
MansellM., GrimesA.J.Red and white cell abnormalities in chronic renal failure. Br J Haem1979; 42: 169–174.
16.
SummerfieldG.P., BellinghamA.J., ManloveL., ForbesA.M., GoldsmithH.J.Erythrocyte metabolism in patients on haemodialysis and continuous ambulatory peritoneal dialysis. Clin Sci1982; 62: 479–488.
17.
RaidisP.C., PapadimitriouM., MetaxasP., ValtisD.J.Haemoglobin-oxygen dissociation curve in patients on regular haemodialysis. Proceedings of the European Dialysis and Transplantation Society.1978; 14: 200–206.
18.
LongneckerR.E., GoffinetJ.A., HendlerE.D.Blood loss from maintenance haemodialysis. Trans Am Soc Artif Intern Organs1974; 20: 135–142.
19.
MilmanV., ChristensenT.E., PedersenN.S., VisfeldtJ.Serum ferritin and bone marrow iron in non-dialysis, peritoneal dialysis and haemodialysis patients with chronic renal failure. Acta Med Scand1980; 207: 201–205.
CatersonR.J., SavdieE., RaikE., CouttsD., MahonyJ.F.Heinz-body haemolysis in haemodialysed patients caused by chloramines in Sydney tap water. Med J Aust1982; 2: 367–368.
22.
MatterB.J., PedersonJ., PsimenosG., LindemanR.D.Lethal copper intoxication in haemodialysis. Trans Am Soc Artif Int Organs1969; 15: 309–315.
23.
CarlsonD.J., ShapiroF.L.Methaemoglobin from well water nitrates; a complication of haemodialysis. Ann Intern Med1970; 73: 757–759.
24.
CastaldiP.A., RozenbergM.C., StewartJ.H.The bleeding disorder of uremia, a qualitative defect. Lancet1966; 1: 66–68.
25.
MarcusA.J.Platelet function. N Eng J Med1969; 280: 1213–1330.
26.
SteinerR.W., CogginsC., CarvalhoA.C.A.Bleeding time in uremia: a useful test to assess clinical bleeding. Am J Haematol1979; 7: 107–117.
27.
RabinerS.F.Uremic bleeding. In SpaetT.H. ed. Progress in thrombosis and haemostasis.Grune and Stratton, New York1972; 233–250.
28.
DavisJ.W., McFieldJ.R., PhillipsP.E., GrahamB.A.Effects of exogenous urea, creatinine and quanidinosuric acid on human platelet aggregation in vitro. Blood1972, 39: 388–397.
29.
DaviesD.T.P., HughesA., LomaxG.D., TonksR.S.Hypermagnesaemia and platelet function in uraemic bleeding. Lancet1968; 1: 301–302.
30.
RemuzziG., CavenaghiA.E., MeccaG., DonatiM.B., De GaetanoG.Prostacyclin-like activity and bleeding in renal failure. Lancet1977; 2: 1195–1197.
31.
RemuzziG., MarchesiD., LivioM.Altered platelet and vascular prostaglandin generation in patients with renal failure and prolonged bleeding time. Thromb Res1978; 13: 1007–1015.
32.
SmithM.C., DunnM.J.Impaired platelet thromboxane production in renal failure. Nephron1981; 29: 133–137.
33.
LindnerA., CharraB., SherrardD.J., ScribnerB.H.Accelerated atherosclerosis in prolonged maintenance haemodialysis. N Engl J Med1974; 290: 697–701.
34.
TurneyJ.H., WoodsH.F., FewellM.R., WestonM.J.Factor VIII complex in uraemia and effects of haemodialysis. Br Med J1981; 282: 1653–1656.
35.
WarrellR.P., HultinM.B., CollerB.S.Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure. Am J Med1979; 66: 226–228.
KaufmannR.H., VeltkampJ.J., VanTilburgN.H., VanesL.A.Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am J Med1978; 65: 607–613.
38.
JacksonC.A., GreavesM., PattersonA.D., BrownC.B., PrestonF.E.Relationship between platelet aggregation thromboxane synthesis and albumin concentration in nephrotic syndrome. Br J Haematol1982; 52: 69–77.
39.
JansonP.A., JubelirerS.J., WeinsteinM.J., DeykinD.Treatment of the bleeding tendency in uraemia with cryoprecipitate. N Engl J Med1980; 303: 1318–1322.
40.
MannucciP.M., RemuzziG., PusineriF.Deamino-8-D-Arginine Vasopressin shortens the bleeding time in uremia. New Engl J Med1983; 308: 8–12.
41.
MarcusA.J.Moschcowitz Revisited. N Engl J Med1982; 307: 1447–1448.
42.
BukowskiR.M., HewlettJ.S., ReimerR.R.Therapy of thrombotic thrombocytopenic purpura: An overview. Serum Thromb Hemostas1981; VII: 1–8.
43.
LockwoodC.M., PetersD.K.Plasma exchange in glomerulonephritis and related vasculitides. Ann Rev Med1980; 31: 167–179.
44.
CardellaC.J., SuttonD., FalkJ.A.Effects of intensive plasma exchange on renal transplant rejection and serum cytotoxic antibodies. Transplant Proc1978; 10: 617–619.
45.
MollisonP.L.Some clinical consequences of red cell incompatibility. J Roy Col Phys Lond1979; 13: 15–20.
46.
MyhreB.A.Fatalities from Blood Transfusion. JAMA1980; 244: 1333–1335.
47.
OpelzG., SengarD.F.S., MickeyM.R.Effect of blood transfusions on subsequent kidney transplants. Transplant Proc1973; 5: 253–259.
GuerreroI.C., SchreiberA.D., MacGregorR.R.Studies of the plasma factor which induces augmented granulocyte adherence during haemodialysis. Nephron1981; 27: 79–83.
54.
HammerschmidtD.E., WeaverL.J., HudsonL.D., CraddockP.R., JacobH.S.Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet1980; 1: 947–949.
55.
CraddockP., FehrJ., BrighamK., KronenbergR., JacobH.Complement and leukocyte-mediated pulmonary dysfunction in haemodialysis. N Engl J Med1977; 296: 769–774.
56.
HakimR.M., LowrieE.G.Haemodialysis-associated neutropaenia and hypoxaemia: the effect of dialyzer membrane materials. Nephron1982; 32: 32–39.
57.
BurnsC.B., ScheinhornD.J.Hypoxaemia during haemodialysis. Arch Intern Med1982; 142: 1350–1353.
58.
ChenT., FreidmanH., BelmonteM., SmithA.Haemodynamic changes during haemodialysis. Relationships to arterial Po2. Abstract. 9th Annual Clinical Dialysis and Transplant Forum, Boston 1979; 30.
59.
KunoriT., FehrmanI., RingdenO., MollerE.In vitro characterization of immunological responsiveness of uraemic patients. Nephron1980; 26: 234–239.
